Health in Netherlands

1,118 indicators covering health for Netherlands.

IndicatorLatest Year10-yr change Rank
Domestic general government health expenditure per capita 4,356 current US$ 2023 up 14.1% 17th
Share of out of pocket expenditure on healthcare 11.79 2024 up 1.7% 159th
Tuberculosis treatment success rate in new and relapsed cases 79 2023 down 10.2% 125th
Share of public expenditure on healthcare by country 68.37 2023 down 0.9% 59th
Private health expenditure per person 2,443 2023 up 51.2% 5th
Public healthcare spending share gdp 6.72 2023 down 7.3% 26th
Health spending per person by source 5,283 2023 up 46.7% 15th
Poliomyelitis - number of reported cases 0 2018 β€” 8th
Number of new hiv infections per year 311.89 2023 down 54.5% 103rd
Rubella vaccination coverage 89 2024 down 7.3% 103rd
Deaths from aids un 70.89 2023 down 4.5% 102nd
Mortality rate among children ages 10 to 14 years 0.385 2020 down 26.0% 179th
Cost healthy diet 3.17 2024 up 43.4% 160th
Terrorism deaths by region 0 2021 β€” 58th
Medical doctors 69,985 2023 up 25.7% 36th
Adults (ages 15-49) newly infected with HIV 500 2023 down 19.4% 87th
Number of new hiv child infections vs number of infections averted due 17.72 2023 up 9.5% 72nd
Mean systolic blood pressure 120.4 2015 down 2.2% 135th
UHC Service Coverage sub-index on infectious diseases 98 2023 unchanged 51st
UHC Service Coverage sub-index on service capacity and access 94 2023 down 3.1% 26th
UHC Service Coverage sub-index on reproductive, maternal, newborn and 90 2023 unchanged 9th
UHC Service Coverage Index 85 2023 up 2.4% 16th
UHC Service Coverage sub-index on noncommunicable diseases 63 2023 up 12.5% 100th
Stillbirth rate 2.15 2023 down 11.8% 183rd
Number of stillbirths 362 2023 down 14.6% 120th
Hepb3 number unvaccinated 25,450 2023 down 71.2% 75th
Rotavirus vaccines completed dose (RotaC) immunization coverage among 73.0% 2025 β€” 94th
Young people (ages 15-24) newly infected with HIV 100 2023 down 50.0% 83rd
Tb related deaths hiv 6 2023 unchanged 124th
Smoking bans in public places 8 2022 β€” 1st
Current health expenditure (CHE) as percentage of gross domestic 9.8% 2023 down 6.4% 29th
External health expenditure (EXT) as percentage of current health 0.0% 2023 down 51.2% 140th
Domestic general government health expenditure (GGHE-D) as percentage 68.4% 2023 down 0.9% 58th
Out-of-pocket expenditure as percentage of current health expenditure 12.0% 2023 up 4.3% 158th
Domestic general government health expenditure (GGHE-D) as percentage 6.7% 2023 down 7.3% 26th
Domestic general government health expenditure (GGHE-D) as percentage 15.6% 2023 up 2.1% 39th
Domestic private health expenditure (PVT-D) as percentage of current 31.6% 2023 up 2.1% 110th
Current health expenditure (CHE) per capita in US$ 6,372 2023 up 15.2% 12th
Domestic private health expenditure (PVT-D) per capita in US$ 2,015 2023 up 17.6% 4th
Domestic general government health expenditure (GGHE-D) per capita in 4,356 2023 up 14.1% 16th
Total healthcare expenditure gdp 9.83 2023 down 6.4% 29th
Health expenditure government expenditure 15.56 2023 up 2.1% 39th
Mumps - number of reported cases 150 2025 up 70.5% 54th
Incidence of tuberculosis (per 100 000 population) 0.19 2023 up 5.6% 136th
Hib vaccine 89 2024 down 7.3% 108th
Congenital Rubella Syndrome - number of reported cases 0 2025 β€” 16th
External health expenditure (EXT) per capita in US$ 0.6678 2023 down 43.8% 129th
Dentists 10,136 2023 up 21.9% 38th
Nursing and midwifery personnel 203,188 2023 up 14.2% 29th
Nursing personnel 198,573 2023 up 13.9% 28th
Raised blood pressure (SBP>=140 OR DBP>=90) 23.52 2019 down 24.5% 153rd
Raised blood pressure (SBP>=140 OR DBP>=90) 29.37 2019 down 16.8% 102nd
Hypertension: diagnosis coverage among adults aged 30-79 with 51.3% 2019 up 19.0% 113th
Hypertension among adults aged 30-79 years, prevalence 30.5 2019 down 15.0% 157th
Hypertension effective treatment coverage (controlled hypertension) 22.9% 2019 up 72.2% 62nd
Hypertension: effective treatment coverage (controlled hypertension) 23.9% 2019 up 75.7% 62nd
Hypertension treatment coverage among adults aged 30-79 with 46.6% 2019 up 24.9% 79th
Hypertension treatment coverage among adults aged 30-79 with 42.4% 2019 up 20.8% 96th
Hypertension: diagnosis coverage among adults aged 30-79 with 55.2% 2019 up 22.9% 89th
Hypertension among adults aged 30-79 years, prevalence, crude 38.6 2019 down 5.6% 72nd